INDICATIONS FOR TREATMENT OF HYPER-PHENYLALANINEMIC NEONATE

被引：10

作者：

GUTTLER, F ^{[1
]}

WAMBERG, E ^{[1
]}

机构：

[1] JOHN F KENNEDY INST,DK-2600 GLOSTRUP,DENMARK

来源：

ACTA PAEDIATRICA SCANDINAVICA | 1977年 / 66卷 / 03期

关键词：

D O I：

10.1111/j.1651-2227.1977.tb07904.x

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

页码：339 / 344

页数：6

共 19 条

[1]

BERRY HK, 1966, PEDIATRICS, V37, P102

[2]

Bickel H, 1970, Neuropadiatrie, V1, P379, DOI 10.1055/s-0028-1091826

[3] PHENYLALANINAEMIA - DIFFERENTIAL DIAGNOSIS [J].

BLASKOVICS, ME ;

SCHAEFFLER, GE ;

HACK, S .

ARCHIVES OF DISEASE IN CHILDHOOD, 1974, 49 (11) :835-843

[4] FACTORS DETERMINING BLOOD PHENYLALANINE IN NEONATAL-PERIOD [J].

BURMAN, D ;

HOLTON, JB ;

MORRIS, AF .

CLINICA CHIMICA ACTA, 1975, 62 (02) :325-331

[5]

DONTANVILLE VK, 1973, PEDIATRICS, V51, P531

[6]

FOLLING A, 1934, PHYSIOL CHEM, V227, P169

[7]

GRUTTNER R, 1974, ERBLICHE DEFEKTE KOH, P297

[8]

GUTHRIE R, 1963, PEDIATRICS, V32, P338

[9] PERSISTENT HYPERPHENYLALANINEMIA [J].

GUTTLER, F ;

WAMBERG, E .

ACTA PAEDIATRICA SCANDINAVICA, 1972, 61 (03) :321-&

[10]

GUTTLER F, IN PRESS

← 1 2 →